Viemed Healthcare (Viemed Healthcare) Cash, Cash Equivalents, Marketable Securities : $7.3 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Viemed Healthcare Cash, Cash Equivalents, Marketable Securities?

Viemed Healthcare's quarterly cash, cash equivalents, marketable securities increased from Sep. 2023 ($10.08 Mil) to Dec. 2023 ($12.84 Mil) but then stayed the same from Dec. 2023 ($12.84 Mil) to Mar. 2024 ($7.31 Mil).

Viemed Healthcare's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($28.41 Mil) to Dec. 2022 ($16.91 Mil) and declined from Dec. 2022 ($16.91 Mil) to Dec. 2023 ($12.84 Mil).

Viemed Healthcare Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Viemed Healthcare's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viemed Healthcare Cash, Cash Equivalents, Marketable Securities Chart

Viemed Healthcare Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

13.36

30.98

28.41

16.91

12.84

Viemed Healthcare Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															23.54	10.22	10.08	12.84	7.31

Viemed Healthcare Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Viemed Healthcare (NAS:VMD) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Viemed Healthcare Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Viemed Healthcare's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Viemed Healthcare (Viemed Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viemed Healthcare Inc (NAS:VMD) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

VIJ:Germany

Address

625 E. Kaliste Saloom Road, Lafayette, LA, USA, 70508

Website

https://www.viemed.com

Viemed Healthcare Inc is a provider of equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services.

Executives

Jeremy Trahan	officer: Chief Legal Officer	625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Timothy Smokoff	director	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Nitin Kaushal	director	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Randy E. Dobbs	director	C/O VIEMED HEALTHCARE, INC, 625 E. KALISTE SALOOM RD, LAFAYETTE LA 70508
Bruce D Greenstein	director	901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
William Todd Zehnder	director, officer: Chief Operating Officer	400 E. KALISTE SALOOM ROAD, SUITE 6000, LAFAYETTE LA 70508
Casey Hoyt	director, officer: Chief Executive Officer	625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Michael Moore	officer: President	625 E. KALISTE SALOOM RD., LAFAYETTE LA 70508
Trae Fitzgerald	officer: Chief Financial Officer	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
William Frazier	director, officer: Chief Medical Officer	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Jerome Cambre	officer: Vice President of Sales	625 E KALISTE SALOOM RD, LAFAYETTE LA 70508
Sabrina Heltz	director	625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508
Ewell Patrick Eagan	officer: General Counsel	625 E. KALISTE SALOOM ROAD, LAFAYETTE LA 70508